BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3541948)

  • 1. Immunologic tools to decipher efficacy of BCG immunotherapy in advanced breast cancer: a one year follow up study.
    Saha K; Kapila H; Madan R; Shinghal RN
    Asian Pac J Allergy Immunol; 1986 Dec; 4(2):139-48. PubMed ID: 3541948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy of breast cancer (review of foreign literature)].
    Liapis MA
    Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
    [No Abstract]   [Full Text] [Related]  

  • 3. Effective BCG stimulation in patients treated with melphalan after mastectomy.
    Adler A; Stein JA; Ben-Efraim S
    Isr J Med Sci; 1977 Aug; 13(8):837-43. PubMed ID: 330456
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunology of breast cancer: clinical implications.
    Black MM
    Prog Clin Cancer; 1975; 6():115-37. PubMed ID: 1105675
    [No Abstract]   [Full Text] [Related]  

  • 5. A multiparametric observation of immune competence in breast cancer and its correlation with tumour load and prognosis.
    Das SN; Khanna NN; Khanna S
    Ann Acad Med Singap; 1985 Apr; 14(2):374-81. PubMed ID: 3876055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adjuvant BCG immunotherapy for breast cancer (T1N0M0, T2N0M0)].
    Sakurai T; Okada K; Yokoi H; Maebeya S; Juri M; Takimoto M; Nishimura O; Okada N
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1838-42. PubMed ID: 6476845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic monitoring in carcinoma of the breast.
    Weese JL; Oldham RK; Tormey DC; Barlock AL; Morales A; Cohen MH; West WH; Herberman RB; Alford TC; Shorb PE; Tsangaris NT; Cannon GB; Dean JH; Djeu J; McCoy JL
    Surg Gynecol Obstet; 1977 Aug; 145(2):209-18. PubMed ID: 141745
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
    Gandhi NM; Morales A; Lamm DL
    BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defence systems of the body, immunosuppression and immunotherapy.
    James DG
    J R Nav Med Serv; 1976; 62(2):60-72. PubMed ID: 787517
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction: Immunotherapy of cancer in man, a reality.
    Klein E
    Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostate carcinoma: immunostaging and adjuvant immunotherapy with BCG.
    Guinan PD; John T; Sahadevan V; Crispen R; Nagale V; McKiel C; Ablin RJ
    Natl Cancer Inst Monogr; 1978 Dec; (49):355-60. PubMed ID: 748793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
    Järvinen R; Kaasinen E; Sankila A; Rintala E;
    Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic mechanisms in the prevention and therapy of cancer.
    Fleisher TA; Kersey JH
    Am J Dis Child; 1974 Nov; 128(5):739-42. PubMed ID: 4608684
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: B.C.G. and immunological anergy.
    Lamoureux G; Poisson R
    Lancet; 1974 May; 1(7864):989-90. PubMed ID: 4133674
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro antitumor reactivity of mononuclear leukocytes from cancer patients receiving immunotherapy with BCG.
    Mavligit GM; Hersh EM
    Med Pediatr Oncol; 1978; 5(1):115-26. PubMed ID: 370532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
    Mathé G
    Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
    Thatcher N; Crowther D
    Dev Biol Stand; 1977 Apr 13-15; 38():449-53. PubMed ID: 608536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG as adjuvant immunotherapy for neoplasia.
    Hersh EM; Gutterman JU; Mavligit GM
    Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy: new hope for the cancer patient.
    Costanzi JJ; Goldstein AL
    Am Fam Physician; 1973 Nov; 8(5):150-4. PubMed ID: 4542856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.